Primary Neoplasm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Classification of stage III melanoma is difficult since it comprises a heterogeneous group of patients with divergent prognoses.

The study, published as a preprint and not yet peer reviewed, identifies potential therapeutic targets to be further evaluated in preclinical models.

Patients with metastatic disease experienced a progression-free survival benefit on maintenance therapy but worse toxicity and no overall survival advantage compared with those on active monitoring.

Evidence for sex-related differences in colorectal cancer prognosis is not new, but now a new study points to these differences in primary tumor metabolite profiles.

Surgical resection rates of the primary tumor in metastatic breast cancer has declined in recent years, possibly reflecting changes in practice after trails showed no survival benefit.